Sonja A Swanson1, Matthew Miller, James M Robins, Miguel A Hernán. 1. From the aDepartment of Epidemiology, Harvard School of Public Health, Boston, MA; bDepartment of Health Science, Northeastern University, Boston, MA; cDepartment of Biostatistics, Harvard School of Public Health, Boston, MA; and dHarvard-MIT Division of Health Sciences and Technology, Boston, MA.
Abstract
BACKGROUND: Preference-based instrumental variable methods are often used in comparative effectiveness research. Many instrumental variable studies estimate the local average treatment effect (ie, the effect in the "compliers") under the assumption of monotonicity, ie, no "defiers," and well-defined compliance types. However, the monotonicity assumption has not been empirically tested and the meaning of monotonicity itself is unclear. METHODS: Here, we clarify the definition of local and global monotonicity and propose a novel study design to assess the monotonicity assumption empirically. Our design requires surveying physicians about their treatment plans and prescribing preferences for the same set of patients. We also discuss measures of monotonicity that can be calculated from this survey data. As an illustration, we conducted a pilot study in a survey of 53 physicians who reported treatment plans and prescribing preferences for hypothetical patients who were candidates for antipsychotic treatment. RESULTS: In our study, nearly all patients exhibited some degree of monotonicity violations. In addition, patients could not be cleanly classified as compliers, defiers, always-takers, or never-takers. CONCLUSIONS: We conclude that preference-based instrumental variable estimates should be interpreted cautiously because bias due to monotonicity violations is likely and because the subpopulation to which the estimate applies may not be well defined. Investigators using preference-based instruments may consider supplementing their study with a survey to empirically assess the magnitude and direction of bias due to violations of monotonicity.
BACKGROUND: Preference-based instrumental variable methods are often used in comparative effectiveness research. Many instrumental variable studies estimate the local average treatment effect (ie, the effect in the "compliers") under the assumption of monotonicity, ie, no "defiers," and well-defined compliance types. However, the monotonicity assumption has not been empirically tested and the meaning of monotonicity itself is unclear. METHODS: Here, we clarify the definition of local and global monotonicity and propose a novel study design to assess the monotonicity assumption empirically. Our design requires surveying physicians about their treatment plans and prescribing preferences for the same set of patients. We also discuss measures of monotonicity that can be calculated from this survey data. As an illustration, we conducted a pilot study in a survey of 53 physicians who reported treatment plans and prescribing preferences for hypothetical patients who were candidates for antipsychotic treatment. RESULTS: In our study, nearly all patients exhibited some degree of monotonicity violations. In addition, patients could not be cleanly classified as compliers, defiers, always-takers, or never-takers. CONCLUSIONS: We conclude that preference-based instrumental variable estimates should be interpreted cautiously because bias due to monotonicity violations is likely and because the subpopulation to which the estimate applies may not be well defined. Investigators using preference-based instruments may consider supplementing their study with a survey to empirically assess the magnitude and direction of bias due to violations of monotonicity.
Authors: Krista F Huybrechts; M Alan Brookhart; Kenneth J Rothman; Rebecca A Silliman; Tobias Gerhard; Stephen Crystal; Sebastian Schneeweiss Journal: Am J Epidemiol Date: 2011-09-20 Impact factor: 4.897
Authors: Philip S Wang; Sebastian Schneeweiss; Jerry Avorn; Michael A Fischer; Helen Mogun; Daniel H Solomon; M Alan Brookhart Journal: N Engl J Med Date: 2005-12-01 Impact factor: 91.245
Authors: Ellen C Caniglia; Rebecca Zash; Sonja A Swanson; Kathleen E Wirth; Modiegi Diseko; Gloria Mayondi; Shahin Lockman; Mompati Mmalane; Joseph Makhema; Scott Dryden-Peterson; Kalé Z Kponee-Shovein; Oaitse John; Eleanor J Murray; Roger L Shapiro Journal: Am J Epidemiol Date: 2019-09-01 Impact factor: 4.897
Authors: Ailish Nimmo; Nicholas Latimer; Gabriel C Oniscu; Rommel Ravanan; Dominic M Taylor; James Fotheringham Journal: Transpl Int Date: 2022-06-27 Impact factor: 3.842
Authors: Michael D George; Jesse Y Hsu; Sean Hennessy; Lang Chen; Fenglong Xie; Jeffrey R Curtis; Joshua F Baker Journal: Epidemiology Date: 2022-01-01 Impact factor: 4.822
Authors: Maryse C Cnossen; Thomas A van Essen; Iris E Ceyisakar; Suzanne Polinder; Teuntje M Andriessen; Joukje van der Naalt; Iain Haitsma; Janneke Horn; Gaby Franschman; Pieter E Vos; Wilco C Peul; David K Menon; Andrew Ir Maas; Ewout W Steyerberg; Hester F Lingsma Journal: Clin Epidemiol Date: 2018-07-18 Impact factor: 4.790